Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
JK Ramage, A Ahmed, J Ardill, N Bax, DJ Breen… - gut, 2012 - gut.bmj.com
These guidelines update previous guidance published in 2005. They have been revised by
a group who are members of the UK and Ireland Neuroendocrine Tumour Society with …
a group who are members of the UK and Ireland Neuroendocrine Tumour Society with …
Current status of gastrointestinal carcinoids
IM Modlin, M Kidd, I Latich, MN Zikusoka, MD Shapiro - Gastroenterology, 2005 - Elsevier
Gastrointestinal (GI) carcinoids are ill-understood, enigmatic malignancies, which, although
slow growing compared with adenocarcinomas, can behave aggressively. Carcinoids are …
slow growing compared with adenocarcinomas, can behave aggressively. Carcinoids are …
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non …
M Falconi, DK Bartsch, B Eriksson, G Klöppel… - …, 2012 - karger.com
The WHO 2010 classification [1] distinguishes between well-differentiated neuroendocrine
tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) of small or …
tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) of small or …
The diagnosis and medical management of advanced neuroendocrine tumors
GA Kaltsas, GM Besser, AB Grossman - Endocrine reviews, 2004 - academic.oup.com
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that
originate from endocrine glands such as the pituitary, the parathyroids, and the …
originate from endocrine glands such as the pituitary, the parathyroids, and the …
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
JK Ramage, AHG Davies, J Ardill, N Bax, M Caplin… - Gut, 2005 - gut.bmj.com
JK Ramage*, AHG Davies*, J ArdillÀ, N BaxÀ, M CaplinÀ, A GrossmanÀ, R HawkinsÀ, AM
McNicolÀ, N ReedÀ, R Sutton, R ThakkerÀ, S Aylwin, D Breen, K Britton, K Buchanan, P …
McNicolÀ, N ReedÀ, R Sutton, R ThakkerÀ, S Aylwin, D Breen, K Britton, K Buchanan, P …
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients
AS Kennedy, WA Dezarn, P McNeillie… - American journal of …, 2008 - journals.lww.com
Purpose: The use of 90 Y-microspheres to treat unresectable liver metastases originating
from a variety of neuroendocrine tumors was reviewed. Materials and Methods: This is a …
from a variety of neuroendocrine tumors was reviewed. Materials and Methods: This is a …
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and …
S Gupta, MM Johnson, R Murthy, K Ahrar, MJ Wallace… - Cancer, 2005 - Wiley Online Library
BACKGROUND The objective of this study was to determine the prognostic variables that
influence response and survival in patients with metastatic neuroendocrine tumors who are …
influence response and survival in patients with metastatic neuroendocrine tumors who are …
Carcinoid a comprehensive review
II Schnirer, JC Yao, JA Ajani - Acta Oncologica, 2003 - Taylor & Francis
Carcinoid tumors originate from the neuroendocrine cells throughout the body and are
capable of producing various peptides. Their clinical course is often indolent but can also be …
capable of producing various peptides. Their clinical course is often indolent but can also be …
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the MD Anderson experience
S Gupta, JC Yao, K Ahrar, MJ Wallace… - The Cancer …, 2003 - journals.lww.com
BACKGROUND Carcinoid tumors have a predilection for metastasizing to the liver. The
presence of liver metastases is associated with poor prognosis and also results in significant …
presence of liver metastases is associated with poor prognosis and also results in significant …
Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors
A Roche, BV Girish, T de Baère, E Baudin, V Boige… - European …, 2003 - Springer
Our objective was to report the outcome in patients with liver metastasis from endocrine
tumors who underwent transarterial chemoembolization (TACE) as first-line non-surgical …
tumors who underwent transarterial chemoembolization (TACE) as first-line non-surgical …